United States : Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline

Pers / media: Vakinhoudelijk commentaar

Periode24 jan. 2022

Media-aandacht

1

Media-aandacht

  • TitelUnited States : Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
    Media naam/outletTendersInfo – News
    Land/RegioIndia
    Release datum24/01/22
    PersonenLuc Brunsveld, Christian Ottmann
Alle bekijken 1
Minder bekijken